Platelets and cancer angiogenesis nexus

Area of Science:

• Hematology
• Oncology
• Vascular Biology

Background:

• Platelets are increasingly recognized for their roles beyond hemostasis, particularly in inflammation and cancer.
• Thrombocytosis (elevated platelet count) is frequently observed in cancer patients.
• Tumor cells actively engage platelets via direct and indirect mechanisms, promoting activation and aggregation.

Purpose of the Study:

• To explore the multifaceted role of platelets in cancer progression.
• To investigate the contribution of platelets to tumor angiogenesis and metastatic dissemination.
• To assess the therapeutic potential of targeting platelet function in cancer treatment.

Main Methods:

• Review of existing literature on platelet function in cancer and angiogenesis.
• Analysis of mechanisms by which tumor cells interact with platelets.
• Evaluation of evidence for platelet involvement in blood vessel formation during malignancy.

Main Results:

• Platelets are key contributors to metastatic dissemination.
• Platelets transport critical proangiogenic and antiangiogenic factors.
• Platelets influence angiogenesis through various mediators including microparticles, microRNA, and surface receptors.
• Platelets stimulate tumor angiogenesis throughout its early and late stages.

Conclusions:

• Platelets significantly promote tumor angiogenesis.
• Interfering with platelet function emerges as a promising antineoplastic therapeutic strategy.